Publicaciones en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (41)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  2. Structural insights into choline-O-sulfatase reveal the molecular determinants for ligand binding

    Acta crystallographica. Section D, Structural biology, Vol. 78, pp. 669-682

2021

  1. CD38 Deficiency Ameliorates Chronic Graft-Versus-Host Disease Murine Lupus via a B-Cell-Dependent Mechanism

    Frontiers in Immunology, Vol. 12

  2. Production of Cross-Linked Lipase Crystals at a Preparative Scale

    Crystal Growth and Design, Vol. 21, Núm. 3, pp. 1698-1707

  3. The isolated GTPase-activating-protein-related domain of neurofibromin-1 has a low conformational stability in solution

    Archives of Biochemistry and Biophysics, Vol. 700

2020

  1. N-succinylamino acid racemases: Enzymatic properties and biotechnological applications

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1868, Núm. 4

2019

  1. A novel cysteine carbamoyl-switch is responsible for the inhibition of formamidase, a nitrilase superfamily member

    Archives of Biochemistry and Biophysics, Vol. 662, pp. 151-159

2016

  1. Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: Relation with risk and phenotype in a Spanish cohort

    Immunobiology, Vol. 221, Núm. 9, pp. 927-933

  2. Identification of multiple transferrin species in the spleen and serum from mice with collagen-induced arthritis which may reflect changes in transferrin glycosylation associated with disease activity: The role of CD38

    Journal of Proteomics, Vol. 134, pp. 127-137

  3. Pitx2 impairs calcium handling in a dose-dependent manner by modulating Wnt signalling

    Cardiovascular Research, Vol. 109, Núm. 1, pp. 55-66

  4. Supporting data for the MS identification of distinct transferrin glycopeptide glycoforms and citrullinated peptides associated with inflammation or autoimmunity

    Data in Brief

2013

  1. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis

    Cell Transplantation, Vol. 22, Núm. 5, pp. 839-854

2012

  1. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy

    Cell Research, Vol. 22, Núm. 7, pp. 1181-1198

2010

  1. CD40: Novel association with crohn's disease and replication in multiple sclerosis susceptibility

    PLoS ONE, Vol. 5, Núm. 7, pp. 1-4

2009

  1. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

2008

  1. Differential splicing, disease and drug targets

    Infectious Disorders - Drug Targets, Vol. 8, Núm. 4, pp. 241-251

2007

  1. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus

    Tissue Antigens, Vol. 70, Núm. 3, pp. 233-237

  2. Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy

    Annals of the Rheumatic Diseases

  3. HO-1 promoter polymorphism associated with rheumatoid arthritis

    Arthritis and Rheumatism, Vol. 56, Núm. 12, pp. 3953-3958